The independent evaluation analyzes 20 pharmaceuticals for their advances in drugs, vaccines and diagnostics in 113 low- and middle-income countries. The entry Novartis leads for the second consecutive edition the drug access index was first published in Correspondents.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The independent evaluation analyzes 20 pharmaceuticals for their advances in drugs, vaccines and diagnostics in 113 low- and middle-income countries. The entry Novartis leads for the second consecutive edition the drug access index was first published in Correspondents.